| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/22/2007 | DE10101522B4 Neue pharmazeutische Verwendung einer Kombination aus Ascorbat und mindestens einem Fibrinolysehemmer New pharmaceutical use a combination of ascorbate and at least one Fibrinolysehemmer |
| 02/22/2007 | CA2619704A1 Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion |
| 02/22/2007 | CA2619695A1 Therapy with cd4 binding peptides and radiation |
| 02/22/2007 | CA2619480A1 Method of using potassium channel inhibiting compounds |
| 02/22/2007 | CA2618791A1 Novel mucin-type glycoprotein and use thereof |
| 02/22/2007 | CA2618653A1 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
| 02/21/2007 | EP1754714A1 cyclic peptide derivatives as inhibitors of integrin alpha v beta 6 |
| 02/21/2007 | EP1754707A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 02/21/2007 | EP1754705A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 02/21/2007 | EP1754513A2 Use of 8-hexadecene-1,16-dicarboxylic acid as a care agent for promoting the horny layer cohesion |
| 02/21/2007 | EP1754482A1 Use of an ascomycin for the treatment of blepharitis |
| 02/21/2007 | EP1753712A1 Amino-propanol derivatives |
| 02/21/2007 | EP1753436A2 Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle |
| 02/21/2007 | EP1753435A1 Use of a combination of ethinyl estradiol and chlormadinone acetate for the production of a medicament |
| 02/21/2007 | EP1603517B1 Skin care product containing tall oil fatty acids and vegetable oils for dry and scaling skin and treatment of psoriasis, dermatitis, and eczemas |
| 02/21/2007 | EP1536697B1 Composition containing in combination at least one gourd oil and at least one borage oil, use thereof as medicine, as dermatological or dermato-cosmetic agent |
| 02/21/2007 | EP1529047B1 New purine derivatives |
| 02/21/2007 | EP1523325A4 Methods and compositions for treating polycystic ovary syndrome |
| 02/21/2007 | EP1501508B1 Inhibitors of histone deacetylase |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | EP1328254B1 Lipid formulations for target delivery |
| 02/21/2007 | EP1276459B8 Cosmetic or dermatological cream composition, the preparation and the use thereof |
| 02/21/2007 | EP1140071B1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 02/21/2007 | CN1918127A New cyclocompound having 4-pyridylalkylthio group to which sustituted or unsubstituted amino group is introduced |
| 02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 02/21/2007 | CN1918113A Androgen receptor modulators |
| 02/21/2007 | CN1917884A External preparation for treating painful skin wound |
| 02/21/2007 | CN1917878A Method of stimulating hair growth |
| 02/21/2007 | CN1917868A Composition, comprising l-serine, l-isoleucine, folic acid and trace elements, for treating psoriasis |
| 02/21/2007 | CN1917856A Oral moisture keeping agent for skin and functional food an drink |
| 02/21/2007 | CN1916013A Pharmaceutical compounds |
| 02/21/2007 | CN1915404A Chinese traditional medicine for treating psoriasis |
| 02/21/2007 | CN1915374A Medication of medical broth for treating condyloma acuminatum in type of heat toxin, and preparation method |
| 02/21/2007 | CN1915373A External scattering medication for treating tinea of feet, and preparation method |
| 02/21/2007 | CN1915371A Medication for treating burn and scald, frostbite, and preparation method |
| 02/21/2007 | CN1915370A Massage cream of Chinese herbal medicine for removing spots and whitening skin |
| 02/21/2007 | CN1915367A Medicinal food for treating disease of pruritus in winter, and preparation method |
| 02/21/2007 | CN1915362A Medication of medical broth for treating disease of pruritus in winter in type of deficiency of liver-yin and kidney-yin, and preparation method |
| 02/21/2007 | CN1915357A Medication of medical broth for treating condyloma acuminatum in type of qi deficiency, and preparation method |
| 02/21/2007 | CN1915351A Composition of Chinese traditional medicine in use for treating burn and scald, and product for resolving poxes, and preparation method |
| 02/21/2007 | CN1915348A Medication of medical broth for treating congestion type condyloma acuminatum, and preparation method |
| 02/21/2007 | CN1915334A Medication of medical broth for treating pruritus in winter in bleeding due to blood-heat type, and preparation method |
| 02/21/2007 | CN1915332A Steaming and washing medication for treating pruritus in winter, and preparation method |
| 02/21/2007 | CN1915328A Medication of steeping foot for treating tinea of feet, and preparation method |
| 02/21/2007 | CN1915292A Application of acetylcholine esterase inhibitor medication of Yidancao extractive as cholinomimetic |
| 02/21/2007 | CN1915291A Medication of medical broth for treating damp-heat type pruritus in winter |
| 02/21/2007 | CN1915284A Medication of steeping foot for treating damp-heat type tinea of feet, and preparation method |
| 02/21/2007 | CN1915253A Exterior coating medication for treating tinea of feet, and preparation method |
| 02/21/2007 | CN1915243A Exterior coating medication for treating ulcer in the oral cavity, and preparation method |
| 02/21/2007 | CN1915231A Use of nonsteroidal in preparing drug of antiinflammatory agents |
| 02/21/2007 | CN1301255C Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 02/21/2007 | CN1301124C Chinese traditional medicine liquor for treating chronic dermatopathy |
| 02/21/2007 | CN1301119C External use traditional Chinese medicine for treating beriberi |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179910 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors |
| 02/20/2007 | US7179901 Renal regulatory elements and methods of use thereof |
| 02/20/2007 | US7179825 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179821 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain |
| 02/20/2007 | US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid |
| 02/20/2007 | US7179810 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 02/20/2007 | US7179804 Tachykinin receptor antagonists |
| 02/20/2007 | US7179789 Peptide copper complex with corticosteroid, metronidazole, sulfacetamide, sulfur, and/or azelaic acid for topical administration; cosmetics |
| 02/20/2007 | US7179786 Variants of the NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and their use |
| 02/20/2007 | US7179771 Composition |
| 02/20/2007 | US7179493 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 02/20/2007 | US7179491 Contacting marine oil with an effective amount of a silica under a vacuum;contacting the oil with an effective amount of a bleaching clay;separating the silica from the oil; and separating the clay from the oil |
| 02/20/2007 | US7179476 Medical composition for external use for dermatosis |
| 02/20/2007 | CA2455050C Crystals including a malic acid salt of n-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3h-indole-3-ylidene) methyl]-2, 4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
| 02/20/2007 | CA2422374C Purine derivatives |
| 02/20/2007 | CA2344574C Thyroid receptor ligands |
| 02/20/2007 | CA2151438C Thermostable trehalose-releasing enzyme, and its preparation and uses |
| 02/15/2007 | WO2007019453A2 Treatment of wounds using il-17b |
| 02/15/2007 | WO2007018846A2 Use of interferon- tau for reduction of scar tissue formation |
| 02/15/2007 | WO2007018248A1 Pyridone compound |
| 02/15/2007 | WO2007018137A1 Multikinase inhibitor |
| 02/15/2007 | WO2007018124A1 Agent for enhancing collagen production and utilization of the same |
| 02/15/2007 | WO2007017176A1 Wound-healing composition |
| 02/15/2007 | WO2006103119A3 Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics |
| 02/15/2007 | WO2006009975A3 Histamine to treat disorders affecting muscle function |
| 02/15/2007 | US20070037996 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 02/15/2007 | US20070037995 A Substantially Cell Membrane Impermeable Compound And Use Thereof |
| 02/15/2007 | US20070037864 Intermediates for the preparation of lipoxin A4 analogs |
| 02/15/2007 | US20070037851 Inhibits binding of CCR3 ligands such as eotaxins to their target cells; inhibits physiological effects of binding; therapeutic and prophylactic agents for asthma, rhinitis, dermatitis, urticaria, conjunctivitis, inflammatory bowel; tissue infiltration of eosinophils, basophils, activated T cells |
| 02/15/2007 | US20070037834 Bicyclic pyrimidine derivatives |
| 02/15/2007 | US20070037832 2-butylamino-8-hydroxy-9-(6-methyl-3-pyridylmethyl)adenine; interferon inducing activity; antiviral, antiallergic agent; immune response modulator; hepatitis B and C, asthma, atopic dermatitis |
| 02/15/2007 | US20070037803 Benzimidazole derivatives |
| 02/15/2007 | US20070037782 Therapeutic agent for ageing macular degeneration |
| 02/15/2007 | US20070037765 gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 02/15/2007 | US20070037750 Exendin agonist composed of a peptide in which at least one amino acid residue is acylated with a dicarboxylic acid; the amino acid residues are an internal lysine residue, an N-terminal amino acid residue, and/or a C-terminal amino acid residue; treatment of glucagonoma |
| 02/15/2007 | US20070037606 Transmitter of wireless microphone, receiver for wireless microphone, portable information communication device, and wireless microphone communication system |
| 02/15/2007 | US20070037136 Harvesting, separating, culturing and exposing tissue to antiproliferative agents, monitoring variation in tissue propagation; immunotherapeutics; wound healing agents |
| 02/15/2007 | US20070036860 Treatment of allergic conditions |
| 02/15/2007 | US20070036854 Therapeutic applications of pro-apoptotic benzodiazepines |
| 02/15/2007 | US20070036813 Expression vector comprising nucleotide sequences coding endothelial growth factor protein for use in prevention and treatment of cell proliferative and eye disorders |
| 02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
| 02/15/2007 | US20070036768 Systems and methods for treating patients with processed lipoaspirate cells |
| 02/15/2007 | US20070036735 Skin external preparation |
| 02/15/2007 | DE202006017823U1 Dietic food with increased effect of free radical binder, useful, e.g. for the treatment of allergic condition disease, comprises a protein and a sugar |
| 02/15/2007 | DE102006037632A1 Microbiological mixture, useful for applying on a skin surface to treat e.g. fungus and bacteria infections, comprises piezoelectric nano-structures, reductive/oxidative microorganisms, conjugated biopolymer and/or 5-aminolevulinic acid |